BLOG / 🇮🇳 India / distress insolvency · · daily

India MCA Insolvency Liquidation Filings — November 05, 2026

India MCA Insolvency & Restructuring Monitor

By Gunpowder Editorial ·

6 high priority 6 total filings analysed

Executive Summary

This digest covers six Indian insolvency and restructuring filings dated around 5 November 2026, all within the stream's IBC/NCLT focus.

The dominant theme is active creditor-driven and tribunal-driven process milestones: a fresh CIRP admission at Quasar India (materiality 9/10), a 14-month-old CIRP at Quadrant Televentures where only about 48% of claims (₹28.17 bn of ₹59.16 bn) have been admitted and unsecured financial creditor admissions sit at just 8.8%, and an NCLAT reversal annulling the CIRP at FTF Pharma, a subsidiary of Shilpa Medicare. Simbhaoli Sugars extended its resolution plan deadline to 21 November 2026, signalling a stalled or slow CoC process tied to cane allocation litigation. Go Digit's NCLT-supervised amalgamation vote drew near-unanimous public-shareholder support, a constructive corporate governance event. The filings provide no period-over-period financial metrics, so quantitative trend analysis is limited; the most material quantitative datapoint is the Quadrant claim-admission ratio. Market implication: stressed-asset and distressed-credit participants should focus on claim-admission dynamics and resolution timelines rather than on earnings trends.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Insolvency

Tracking the trend? Catch up on the prior India MCA Insolvency Liquidation Filings digest from November 04, 2026.

Investment Signals (7)

  • NCLAT set aside the 9 Sept 2026 NCLT admission of CIRP against wholly owned subsidiary FTF Pharma; company states no quantifiable impact on the listed entity [POSITIVE/NEUTRAL, low materiality 4/10]

  • Shareholders approved the Scheme of Amalgamation with Go Digit Infoworks with ~99.999% of public votes in favour on ~91.76% public participation; no cash consideration payable

  • Secured financial creditor claims admitted at 85.1% (₹7.04 bn of ₹8.27 bn) versus unsecured financial creditors at 8.8% (₹0.16 bn of ₹18.11 bn), indicating recovery prospects are concentrated in secured lenders [BEARISH for equity]

  • CoC extended resolution plan submission deadline from 5 Nov to 21 Nov 2026, the second visible timeline slippage, pointing to a prolonged CIRP that began 11 July 2024

  • ▲

    CIRP admitted 31 Oct 2026 with Interim Resolution Professional appointed; claims deadline 14 Nov 2026 and estimated process closure 29 Apr 2027

  • ▲

    RTA change of corporate office to Kokapet, Telangana effective 1 Dec 2026 with no financial impact; routine administrative item

  • Cross-filing pattern (BEARISH)
    ▲

    Four of six filings involve active CIRP or tribunal proceedings, and three of those four show creditor claim or deadline frictions rather than clean resolution

Risk Flags (6)

  • Total claims ₹59.16 bn with only ~48% admitted; unsecured financial creditors admitted at 8.8%, indicating severe impairment for unsecured lenders and likely equity wipeout risk

  • CIRP commenced 2 Sept 2025 and is over 14 months old with claims still being revised post 3 Nov 2026 NCLT order, suggesting an extended timeline

  • Fresh CIRP admitted with IRP appointed and financial creditors required to file claims electronically; board powers transfer to the IRP, creating governance and equity-value uncertainty [HIGH RISK, materiality 9/10]

  • ▼

    Plan deadline extended to 21 Nov 2026 with unresolved cane allocation appeals pending before the Allahabad High Court, a regulatory and litigation overhang on asset value

  • FTF Pharma/Litigation Reversal Risk [MEDIUM RISK]
    ▼

    The NCLAT annulment was appealed by a suspended director against an operational creditor, and the underlying Technology Transfer Agreement milestone and testing-invoice disputes remain unresolved, so the matter could re-escalate

  • Scheme was modified per IRDAI advisory and remains subject to regulatory approvals; promoter votes were excluded, so approval depends on public shareholders and regulators

Opportunities (6)

  • Secured financial creditor admission rate of 85.1% (₹7.04 bn admitted) points to a clearer recovery path for secured lenders, relevant to distressed-debt investors evaluating claim purchases

  • Unsecured claims admitted at only 8.8% (₹0.16 bn of ₹18.11 bn) create potential mispricing in claim-trading markets if disputed claims are later admitted at a higher rate [OPPORTUNITY, speculative]

  • Near-unanimous public-shareholder approval (~99.999%) and removal of cash consideration make the merger likely to complete, with potential simplification of the group structure

  • Annulment of CIRP at FTF Pharma removes a contingent liability overhang for the listed parent, supporting a re-rating if the company reports no further quantifiable exposure

  • Extended deadline of 21 Nov 2026 offers an entry window for resolution applicants; the cane allocation appeal outcome will be a key valuation input [OPPORTUNITY, event-driven]

  • CIRP timeline to 29 Apr 2027 implies a potential asset-value unlock through resolution plan or liquidation, relevant to special-situations investors [OPPORTUNITY, longer horizon]

Sector Themes (5)

  • Contested CIRP Admissions and Annulments
    ◆

    Two of six filings (FTF Pharma/Shilpa, Quadrant) show tribunal admission decisions being challenged or revised, indicating higher appellate and claim-dispute frequency in IBC proceedings in this cycle

  • Secured Versus Unsecured Creditor Divergence
    ◆

    Quadrant's 85.1% secured versus 8.8% unsecured admission rates illustrate the recovery hierarchy under IBC and suggest unsecured creditors are most exposed in Indian resolution outcomes

  • Resolution Timeline Slippage
    ◆

    Simbhaoli (CIRP since July 2024, plan deadline extended), Quadrant (14+ months) and Quasar (estimated closure April 2027) show that IBC timelines are routinely stretched, which weighs on recovery values

  • Corporate Governance Via Tribunal-Supervised Mergers
    ◆

    Go Digit's NCLT-convened scheme vote with clean public-shareholder approval reflects an orderly, regulator-supervised restructuring channel distinct from distressed insolvency, with IRDAI involvement shaping scheme terms

  • Administrative Disclosures as Noise
    ◆

    Punj Lloyd's RTA address change illustrates that a material share of listed-company IBC-adjacent filings carry no financial information and should be filtered out of risk monitoring

Watch List (6)

Filing Analyses (6)
Shilpa Medicare Limited Insolvency positive materiality 4/10

05-11-2026

Shilpa Medicare Limited disclosed that the National Company Law Appellate Tribunal (NCLAT), New Delhi, by order dated 4 November 2026, set aside the NCLT Ahmedabad Bench order dated 9 September 2026 that had admitted Corporate Insolvency Resolution Process (CIRP) proceedings against FTF Pharma Private Limited, its wholly owned subsidiary, and consequently the CIRP stands annulled. The company states there is no quantifiable impact on the listed entity from the earlier order being annulled. The appeal was filed by Mr. Abhay Sapre, a suspended director of FTF Pharma, against the operational creditor Immacule Lifesciences Private Limited.

  • · NCLAT order dated 4 November 2026 in Comp. App. (AT) (Ins) No. 1781 of 2026 set aside the NCLT Ahmedabad order dated 9 September 2026 (C.P. (IB) No. 346 (Ahm) of 2025)
  • · Company received the order on 5 November 2026 and disclosed it under Regulation 30 of SEBI Listing Regulations
  • · Company states the appeal's underlying dispute concerns a Technology Transfer Agreement with an operational creditor, with disputed milestone payments and a disputed invoice for third-party testing
  • · Annulment of CIRP is characterised by the company as having no impact on the listed entity
Quasar India Limited Insolvency negative materiality 9/10

05-11-2026

Quasar India Limited disclosed to BSE that the National Company Law Tribunal (NCLT), New Delhi Bench, Court-V, has ordered the commencement of a Corporate Insolvency Resolution Process (CIRP) against the company, with an order date of 31 October 2026. Raghunath Sabanna Bhandari has been appointed Interim Resolution Professional, and creditors are required to submit claims with proof by 14 November 2026. The filing contains no quantitative financial results, so no period-over-period performance comparison is available.

  • · Insolvency commencement order dated 31-10-2026, uploaded to NCLT website on 03-11-2026
  • · Estimated closure date of the insolvency resolution process: 29-04-2027
  • · Claims submission deadline: 14 November 2026; financial creditors must file claims electronically only
  • · Public announcements published 5 November 2026 in Financial Express (New Delhi, English) and Jansatta (New Delhi, Hindi)
  • · Company's incorporation date: 19-04-1979; CIN L67190DL1979PLC009555; registered office in New Delhi
  • · Filing made under Regulation 30 of SEBI (LODR) Regulations, 2015, following an earlier intimation on 04 November 2026
Go Digit General Insurance Limited Insolvency positive materiality 7/10

05-11-2026

Go Digit General Insurance Limited announced that equity shareholders approved the Scheme of Amalgamation with its wholly owned subsidiary-type transferor Go Digit Infoworks Services Private Limited at a NCLT-convened meeting held on 5 November 2026. Resolution No. 1 cleared the requisite majority, and the public shareholder majority test was also met, with about 99.999% of public votes cast in favour of the Scheme (approximately 91.76% of public shares participated). Promoter and promoter group votes were recorded at 0 in favour and 0 against in the tables, while the promoter group holding (approximately 67.5 crore shares) was excluded from the vote count under Regulation 23(4) of the SEBI Listing Regulations and Section 188(1) of the Companies Act.

  • · The NCLT Mumbai Bench order approving the convening of the meeting is dated 13 August 2026
  • · The meeting ran from 11:00 a.m. to 11:25 a.m. IST via VC/OAVM and was held in the NCLT-appointed presence
  • · No cash consideration is payable under the Scheme; the share exchange ratio applies and the Scheme was modified per IRDAI regulatory advisory
  • · Remote e-voting ran from 1 November 2026 (9:00 a.m. IST) to 4 November 2026 (5:00 p.m. IST), with a record date of 29 October 2026
  • · Scheme approval also requires the Insurance Act, 1938 regulatory approval framework, and the scheme is being disclosed under Regulation 30 read with Schedule III of SEBI LODR
Simbhaoli Sugars Limited Insolvency neutral materiality 7/10

05-11-2026

Simbhaoli Sugars Limited has filed a post-facto intimation of the 5th Meeting of its Committee of Creditors (CoC), held on 04 November 2026 under Section 24 of the IBC, 2016. The CoC extended the last date for submission of Resolution Plans from 05 November 2026 to 21 November 2026 and received an update on cane allocation appeals pending before the Hon'ble Allahabad High Court. The company remains under Corporate Insolvency Resolution Process (CIRP) effective 11 July 2024, with Mr. Anurag Goel as Interim Resolution Professional managing its affairs.

  • · CIRP was initiated w.e.f. 11 July 2024 via adjudicating authority order dated 11 July 2024; Board of Directors powers are suspended
  • · Resolution Plan submission deadline extended from 05 November 2026 to 21 November 2026
  • · CoC update included pending cane allocation appeals before the Hon'ble Allahabad High Court
Quadrant Televentures Limited Insolvency negative materiality 10/10

05-11-2026

Quadrant Televentures Limited has submitted a revised list of creditors to the stock exchanges following an order dated November 3, 2026 from the National Company Law Tribunal (NCLT), Mumbai Bench-I, under Section 7 of the Insolvency and Bankruptcy Code, 2016. The company is undergoing Corporate Insolvency Resolution Process (CIRP) which commenced on September 2, 2025. Total claims received amount to ₹59,16,41,64,891, of which only ₹28,16,83,42,464 (about 48%) have been admitted, with a significant portion of claims being disputed or not admitted, indicating a highly distressed financial position.

  • · The CIRP commenced on September 2, 2025, over 14 months before this filing.
  • · Secured financial creditors (6 claims) have a high admission rate of 85.1% with ₹7,03,54,94,966 admitted out of ₹8,26,68,97,369 claimed.
  • · Unsecured financial creditors (2 claims) have a very low admission rate of 8.8% with only ₹1,59,85,00,000 admitted out of ₹18,11,40,84,601 claimed.
  • · Operational creditors (Government Dues) have a low admission rate of 24.6% with ₹2,84,77,79,811 admitted out of ₹11,58,73,35,604 claimed.
  • · Other operational creditors (329 claims) have a moderate admission rate of 54.5% with ₹2,30,65,58,557 admitted out of ₹4,23,05,34,571 claimed.
  • · Other creditors (5 claims) have a high admission rate of 84.7% with ₹14,37,92,02,400 admitted out of ₹16,96,45,06,016 claimed.
  • · All secured creditors' claims are secured by a first pari-passu charge on the company's immovable and movable properties, including book debts and other current assets.
  • · Personal guarantees have been provided by Mr. P. N. Dhoot and Mr. V. N. Dhoot for the secured debt.
  • · A Mexican company, TDM International, S.A. de CV, has consented to mortgage its property in Mexico to secure the outstanding debt of the corporate debtor.
  • · The largest secured creditor is IDBI Bank Limited (through IDBI Trusteeship Service Limited) with an admitted claim of ₹4,32,88,53,026 (61.53% voting share in CoC).
  • · The largest unsecured financial creditor is Akai Consumer Electronics Indian Limited with an admitted claim of ₹1,59,85,00,000.
  • · The largest operational creditor (Government Dues) is the Ministry of Communications (DDG, Department of Telecommunications) with an admitted claim of ₹2,84,77,79,811.
  • · Employee claims (27 claims) are fully admitted at ₹8,06,730.
  • · No claims from workmen or secured/unsecured financial creditors belonging to any class of creditors were reported.
Punj Lloyd Ltd Insolvency neutral materiality 1/10

05-11-2026

Punj Lloyd Ltd has informed stock exchanges that its Registrar and Share Transfer Agent (RTA), KFin Technologies Limited, will change its corporate office address effective December 1, 2026. The new address is in Kokapet, Telangana, with all other RTA details unchanged. This is a routine administrative update with no financial impact.

  • · New RTA corporate office address: 6,23,24, 25th Floor, South Tower, Rajapushpa West Avenue, Survey No. 115, Kokapet, Serilingampally Mandal, Ranga Reddy District, Telangana - 500075
  • · RTA contact: Telephone 081210 13657, Email [email protected], Website www.kfintech.com
  • · Change effective from December 1, 2026
  • · Company scrip code: 532693 (BSE), Symbol: PUNJLLOYD (NSE)

Get daily alerts with 7 investment signals, 6 risk alerts, 6 opportunities and full AI analysis of all 6 filings

₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: India MCA Insolvency Liquidation Filings

🇮🇳 More from India

View all →